<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Biology of glomerular podocytes
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Biology of glomerular podocytes
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Biology of glomerular podocytes
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Susan Quaggin, MD, FRCP (C)
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Richard J Glassock, MD, MACP
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Brad H Rovin, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Albert Q Lam, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 25, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The healthy kidney filters water-soluble, non-protein-bound metabolic byproducts into the urine but prevents the passage of albumin and other larger essential molecules. This selective filtration occurs across the glomerular capillary wall:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Under normal circumstances, the glomerular capillary wall is extremely permeable to water and small solutes but negligibly to albumin or other proteins of equivalent or larger molecular weight.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Defects in the glomerular capillary wall result in increased permeability to albumin and proteins of similar or even larger size, causing proteinuria.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Electrical potential differences generated by transglomerular flow may modulate the flux of anionic (charged) albumin across the glomerular capillary wall [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The traditional view that the glomerular capillary wall hinders the transit of protein is largely based upon micropuncture studies that demonstrated very low concentrations of albumin in Bowman's space in non-nephrotic animals [
         <a href="#rid2">
          2,3
         </a>
         ]. This view has been challenged by newer data that have demonstrated by intravital 2-photon microscopy, much higher concentrations of albumin in Bowman's space than were reported previously [
         <a href="#rid4">
          4
         </a>
         ]. Given the novelty of the technique of intravital multiphoton microscopy (MPM), these observations need to be validated in other systems and species, especially since they substantially alter our understanding of the pathogenesis of proteinuria [
         <a href="#rid5">
          5-8
         </a>
         ].
        </p>
        <p>
         It is not known, however, why the filter does not routinely clog with large proteins that enter the glomerular basement membrane (GBM). It has been hypothesized that proteins cross the GBM mainly by diffusion rather than by liquid flow, whereas water crosses entirely by flow [
         <a href="#rid9">
          9
         </a>
         ]. Alternatively, generation of a filtration-dependent electric potential difference could influence the glomerular sieving coefficient of albumin
         <em>
         </em>
         [
         <a href="#rid1">
          1
         </a>
         ]. Several factors may prevent clogging of the filter with large proteins. An active transport involving the neonatal Fc receptor has been identified that may remove immunoglobulins that accumulate at the filtration barrier [
         <a href="#rid10">
          10
         </a>
         ]. In addition, human podocytes perform polarized, caveolae-dependent albumin endocytosis [
         <a href="#rid11">
          11
         </a>
         ] and also undergo macropinocytosis at sites of membrane ruffling (a clathrin-independent specialized endocytic process defined by the formation of large vesicles measuring 0.2 to 5 microm in diameter). Free fatty acids associated with serum albumin stimulate macropinocytosis, which may amplify the effect of proteinuria in the nephrotic syndrome [
         <a href="#rid12">
          12
         </a>
         ]. All of these clearance processes may coexist to avoid clogging of the glomerular filter. Genetic or acquired impairment of the clearance machinery may be a common mechanism promoting glomerular diseases.
        </p>
        <p>
         Over the last decade, studies among patients with hereditary proteinuric syndromes have markedly advanced our knowledge of the structure and composition of the glomerular capillary wall and the changes in its composition that lead to proteinuria. However, the changes in the glomerular capillary wall that underlie proteinuria in hereditary diseases do not necessarily account for the proteinuria that accompanies acquired causes of nephrotic syndrome, which are much more common. Thus, the underlying molecular mechanisms of acquired proteinuric diseases remain less well characterized.
        </p>
        <p>
         It is increasingly appreciated that defects in podocyte structure and function result in increased glomerular permeability. This topic review will focus primarily on the biology of glomerular podocytes and defects in podocyte structure that appear to underlie many proteinuric kidney diseases.
        </p>
        <p>
         Reviews of clinical proteinuria, including causes, manifestations, and treatment of specific glomerular disease, are presented separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3084.html" rel="external">
          "Overview of heavy proteinuria and the nephrotic syndrome"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3101.html" rel="external">
          "Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6091.html" rel="external">
          "Evaluation of proteinuria in children"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3041.html" rel="external">
          "Glomerular disease: Evaluation and differential diagnosis in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6101.html" rel="external">
          "Clinical manifestations, diagnosis, and evaluation of nephrotic syndrome in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          GLOMERULAR CAPILLARY WALL
         </span>
         <span class="headingEndMark">
          —
         </span>
         To better appreciate the biology of glomerular podocytes, it is important to understand the structural and functional anatomy of the glomerular capillary wall.
        </p>
        <p>
         The glomerular capillary wall, through which the filtrate must pass, consists of the following three layers:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fenestrated capillary endothelium, extensively coated with a layer of polyanionic glycosaminoglycans and glycoproteins.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glomerular basement membrane (GBM), containing laminin-521, collagen alpha3 alpha4 alpha5 (IV), nidogen, and the heparan sulfate proteoglycan, entactin.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Podocytes (or epithelial cells), which are attached to the GBM by discrete foot processes. The pores between the foot processes (slit pores) are closed by a thin membrane called the slit diaphragm, which functions as a modified adherens junction and may also be permeated by anatomical pores [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Defects in any of the three components of the glomerular capillary wall can lead to proteinuria (
         <a class="graphic graphic_picture graphicRef50018" href="/z/d/graphic/50018.html" rel="external">
          picture 1
         </a>
         ) [
         <a href="#rid14">
          14-17
         </a>
         ]. In addition, crosstalk between podocytes and endothelial and mesangial cells are key to the maintenance of glomerular capillary wall function. As examples, the production of vascular endothelial growth factor (VEGF) by podocytes is necessary for the integrity of the glomerular endothelium [
         <a href="#rid18">
          18
         </a>
         ], and the upregulation and secretion of the podocyte protein, angiopoietin-like-4 (Angptl4) into the glomerular capillary wall causes marked proteinuria in experimental models of nephrotic syndrome [
         <a href="#rid19">
          19
         </a>
         ]. Multiphoton microscopy (MPM) has the necessary spatial and temporal resolution to study complex cell-to-cell interactions between different cell types of the glomerular filtration barrier as well as circulating blood cells and plasma factors in vivo [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          PODOCYTES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Podocytes are terminally differentiated epithelial cells that have large cell bodies and long primary or major processes. The primary processes attach to the underlying glomerular basement membrane (GBM) via multiple foot processes. Adhesion molecules, such as alpha3beta1 integrin complex and dystroglycan (which are present on the basal membrane of foot processes), attach the podocyte to the GBM [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Slit diaphragm
         </span>
         <span class="headingEndMark">
          —
         </span>
         The interdigitating foot processes of adjacent podocytes are joined laterally by slit diaphragms that bridge the intervening filtration slits. The following proteins have been found to comprise the slit diaphragm, which should be considered as a unique category of intercellular junction [
         <a href="#rid21">
          21
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nephrin [
         <a href="#rid22">
          22
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neph1 and neph2 [
         <a href="#rid23">
          23-26
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         FAT1 and FAT2 [
         <a href="#rid27">
          27
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Podocin [
         <a href="#rid28">
          28
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transient receptor potential cation channel 6 (TRPC6) [
         <a href="#rid29">
          29,30
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tight junction proteins, including junctional adhesion molecule A, cingulin, and the huge scaffold protein ZO-1 [
         <a href="#rid31">
          31,32
         </a>
         ]
        </p>
        <p>
        </p>
        <p>
         Slit diaphragms are complex signalling hubs that execute highly specialized functions. They interact with the actin cytoskeleton of podocyte foot processes via linker proteins. These include CD2-associated protein (CD2AP) [
         <a href="#rid33">
          33-35
         </a>
         ], Nck [
         <a href="#rid36">
          36,37
         </a>
         ], zona occludens-1, and the catenins. Selective deletion of Nck expression in podocytes of adult mice leads to proteinuria, glomerulosclerosis, and altered morphology of foot processes [
         <a href="#rid38">
          38
         </a>
         ]. Mutations of some of the genes that encode slit diaphragm proteins cause rearrangement of the actin cytoskeleton, which results in foot process effacement and proteinuria [
         <a href="#rid38">
          38
         </a>
         ]. The use of phosphoproteomics has identified 146 phosphorylation sites on proteins abundantly expressed in podocytes, and as one example, phosphorylation occurs at a site on the podocin protein that is mutated in a genetic form of nephrotic syndrome [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
         Nephrin and neph1 also interact directly with the Par3-aPKC protein complex at the podocyte intercellular junction, suggesting that this complex plays a key role in the establishment and maintenance of podocyte polarity as it does in other polarized epithelia and neurons [
         <a href="#rid40">
          40-42
         </a>
         ].
        </p>
        <p>
         A discussion of the evidence showing that abnormalities of these proteins are causative in some congenital disorders and that autoantibodies targeting nephrin are associated with minimal change disease is presented separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6137.html" rel="external">
          "Congenital nephrotic syndrome"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/117559.html" rel="external">
          "Focal segmental glomerulosclerosis: Genetic causes"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3046.html" rel="external">
          "Minimal change disease: Etiology, clinical features, and diagnosis in adults", section on 'Role of B cells'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Actin cytoskeleton
         </span>
         <span class="headingEndMark">
          —
         </span>
         Podocyte architecture is maintained by a contractile apparatus composed of microfilaments comprising actin, type I and type II myosins, alpha-actinin, talin, paxillin, vinculin, and palladin [
         <a href="#rid43">
          43,44
         </a>
         ]. The opposing effects of molecules such as slit-1-Robo2 and cofilin-1, which counteract filament polymerization, are equally important to the actin cytoskeleton. This cytoskeleton helps to support the glomerular capillary wall, which is subject to the high hydrostatic pressure necessary for glomerular filtration and plays a key role in the foot process architecture (
         <a class="graphic graphic_figure graphicRef50016" href="/z/d/graphic/50016.html" rel="external">
          figure 1
         </a>
         ). The actin cytoskeleton also contributes to the highly motile character of these specialized cells. Mutations in known regulators of the actin cytoskeleton have been implicated in the etiology of proteinuric diseases.
        </p>
        <p>
         Immunofluorescence and confocal microscopy have demonstrated two distinct actin cytoskeletal networks present in the foot processes [
         <a href="#rid45">
          45
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dense actin bundles are present above the level of the slit diaphragm and extend parallel to the longitudinal axis (
         <a class="graphic graphic_figure graphicRef120965" href="/z/d/graphic/120965.html" rel="external">
          figure 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A cortical actin network extends just below the plasma membrane of the foot processes.
        </p>
        <p>
        </p>
        <p>
         Different actin-binding proteins are associated with each of these networks. Thus, whereas alpha-actinin and synaptopodin are associated with the actin bundles above the slit diaphragm, the cortical actin network colocalizes with cortactin [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H51596040">
         <span class="h2">
          Endocytosis, mitochondrial fitness, and autophagy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The concept that podocytes internalize and remove proteins was proposed over 50 years ago. However, the physiological relevance of this has remained elusive, although some studies noted a requirement for endocytic processes in podocytes [
         <a href="#rid46">
          46,47
         </a>
         ]. As an example, podocyte deficiency in the vacuolar protein sorting-34 (Vps34), which controls several vesicular trafficking processes, leads to podocyte vacuolization and defective autophagy, early proteinuria, glomerular scarring, and death [
         <a href="#rid48">
          48
         </a>
         ]. Rat and human podocytes in culture display the two endocytic receptors, megalin and cubilin, which are responsible for the only documented process for protein reabsorption in proximal tubule cells [
         <a href="#rid47">
          47,49
         </a>
         ]. Defective lysosomal activity, as observed in mice deficient in the lysosomal proteinase cathepsin-D, induces apoptotic podocyte death followed by proteinuria and glomerulosclerosis [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
         Mitochondrial health is important for podocyte function and for providing protection from apoptosis [
         <a href="#rid51">
          51
         </a>
         ]. Mitochondria are dynamic organelles that periodically divide (fission) and fuse (fusion). Mitochondrial fission is closely associated with key features of diabetic nephropathy [
         <a href="#rid52">
          52
         </a>
         ]. Podocyte deficiency in dynamin-related protein 1 (Drp1), a protein which is essential for mitochondrial fission, improves mitochondrial fitness and protects against progression of diabetic nephropathy [
         <a href="#rid53">
          53
         </a>
         ]. Some mitochondrial disorders of the podocyte could be amenable to treatment-targeted approaches. As an example, rapamycin has extended the lifespan of mice deficient in the mitochondrial membrane protein prohibitin-2 (PHB2), which develop disorganized mitochondria and missing cristae, foot process effacement, glomerulosclerosis, albuminuria, and kidney function impairment [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
         In addition to endocytosis and mitochondrial fitness, autophagy has been identified as a major pathway that delivers damaged proteins and organelles to lysosomes in order to maintain cellular homeostasis. Autophagy is substantially increased in glomeruli from mice with induced proteinuria and from patients with acquired proteinuric diseases. Podocyte-specific deletion of autophagy-related-5 (Atg5) led to a glomerulopathy in aging mice and strongly increased susceptibility to models of glomerular disease [
         <a href="#rid55">
          55
         </a>
         ]. When Atg5 or Atg7 were mutated during nephrogenesis, mice developed a disease similar to focal segmental glomerulosclerosis (FSGS) [
         <a href="#rid56">
          56
         </a>
         ]. Analogous changes were observed in human idiopathic FSGS kidney biopsy specimens. Podocytes from patients with minimal change disease (MCD) have higher levels of Beclin-1-mediated autophagic activity than glomeruli from FSGS patients. Also, repeat kidney biopsies confirmed that patients maintaining high podocyte autophagic activity retained MCD status, whereas patients with decreased podocyte autophagic activity progressed to FSGS [
         <a href="#rid57">
          57
         </a>
         ]. Impaired autophagy resulting in mitochondrial dysfunction and endoplasmic reticulum stress could play a major role in the progression of podocytopathies.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Foot process effacement and cytoskeleton rearrangement
         </span>
         <span class="headingEndMark">
          —
         </span>
         Flattening of foot processes or foot process effacement is a characteristic histologic finding associated with most primary and secondary glomerular diseases. It could represent a protective response of podocytes to escape detachment from the GBM [
         <a href="#rid58">
          58,59
         </a>
         ]. Rearrangement of the actin cytoskeleton is necessary for foot process effacement to occur, and stabilization of the actin cytoskeleton decreases proteinuria. The actin cytoskeleton is a fluid structure that can be quickly and reversibly reorganized. Experimental evidence suggests it is a direct target of
         <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">
          cyclosporine
         </a>
         A, which is an effective treatment for reducing nephrotic-range proteinuria among patients with MCD [
         <a href="#rid60">
          60
         </a>
         ]. The effect of cyclosporine A on the cytoskeleton appears to be independent of its effect on T cell dysfunction [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
         Other therapies used to treat patients with nephrotic syndrome have also been found to have direct effects on podocyte function distinct from their immunosuppressive effects. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In one study, treatment of cultured podocytes with glucocorticoids (
         <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">
          dexamethasone
         </a>
         ) stabilized the podocyte actin cytoskeleton, protecting against and enhancing recovery from puromycin aminonucleoside (PAN)-induced podocyte injury [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9616" href="/z/d/drug information/9616.html" rel="external">
          Rituximab
         </a>
         may also have a podocyte effect through stabilization of acid sphingomyelinase (ASM)-like phosphodiesterase 3b, which regulates the generation of ceramide [
         <a href="#rid62">
          62
         </a>
         ]. This mechanism is proposed to stabilize the actin cytoskeleton.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Synthetic adrenocorticotropic hormone (ACTH) has been shown to reduce proteinuria and improve glomerular filtration rate (GFR) in patients with membranous nephropathy and other nephrotic syndromes resistant to standard immunosuppressive therapy [
         <a href="#rid63">
          63-65
         </a>
         ]. The benefits of ACTH appear to be mediated by its direct effect on the melanocortin 1 receptor (MCR1) expressed by podocytes [
         <a href="#rid66">
          66,67
         </a>
         ] and not through stimulation of glucocorticoid secretion.
        </p>
        <p>
        </p>
        <p>
         Actin is normally organized into coordinated stress fibers in mature foot processes. Podocyte injury causes the rearrangement of actin to a dense network [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         The cytoskeleton can be altered by at least four different mechanisms:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Direct injury of podocytes can occur by systemic or locally produced toxins (ie, reactive oxygen species [ROS]), viral infection, drugs (
         <a class="drug drug_general" data-topicid="9736" href="/z/d/drug information/9736.html" rel="external">
          pamidronate
         </a>
         , interferon), or local activation of the renin-angiotensin system (RAS) [
         <a href="#rid68">
          68
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/117558.html" rel="external">
          "Focal segmental glomerulosclerosis: Pathogenesis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abnormalities of cytoskeletal structural proteins can adversely affect cytoskeletal dynamics. An example is mutations of alpha-actinin-4, which cause hereditary FSGS [
         <a href="#rid69">
          69
         </a>
         ]. This abnormality increases the affinity of alpha-actinin-4 for actin, which may alter cytoskeletal fluidity. (See
         <a class="medical medical_review" href="/z/d/html/117559.html" rel="external">
          "Focal segmental glomerulosclerosis: Genetic causes", section on 'ACTN4 gene'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The disruption of myosin 1e in mice promotes podocyte injury with foot process effacement [
         <a href="#rid70">
          70
         </a>
         ]. Genetic variations in t
         <em>
          he MYH9
         </em>
         locus were associated with progressive nondiabetic proteinuric kidney disease in individuals of recent African ancestry [
         <a href="#rid71">
          71,72
         </a>
         ], although subsequent analysis showed the causative genetic variants lie in the
         <em>
          APOL1
         </em>
         gene that resides on the same chromosome [
         <a href="#rid73">
          73
         </a>
         ]
         <em>
          . APOL1
         </em>
         encodes an apolipoprotein expressed at high levels in the liver and lower levels in podocytes, endothelial cells, and immune cells. A number of putative mechanisms for podocyte injury in patients carrying
         <em>
          APOL1
         </em>
         risk alleles have been proposed including cationic pore-forming ability, altered autophagy, and direct toxicity [
         <a href="#rid74">
          74-76
         </a>
         ]. The drug inaxaplin, which inhibits cationic influx stimulated by
         <em>
          APOL1
         </em>
         , reduces proteinuria in patients with FSGS and
         <em>
          APOL1
         </em>
         high-risk variants [
         <a href="#rid77">
          77
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/117559.html" rel="external">
          "Focal segmental glomerulosclerosis: Genetic causes", section on 'FSGS in Black patients'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3100.html" rel="external">
          "Focal segmental glomerulosclerosis: Treatment and prognosis", section on 'Investigational therapies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Injury to the slit diaphragm, arising from congenital or acquired disorders (such as drug toxicity or viral infection), can initiate abnormal actin and nephrin signaling, resulting in cytoskeletal reorganization [
         <a href="#rid14">
          14,20-22,25,26,78
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Changes in the structure of the GBM may lead to cytoskeletal derangements, such as in laminin beta 2-deficient mice, in which proteinuria precedes foot process effacement [
         <a href="#rid79">
          79
         </a>
         ], and in mice with the HANAC syndrome Col4a1 mutation that develop proteinuria at birth [
         <a href="#rid80">
          80
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The mechanism by which podocyte injury or mutations in genes for slit diaphragm proteins initiate rearrangement of the cytoskeleton is unclear. Similar intracellular events, such as phosphorylation of constituent proteins, appear to occur during development of the foot processes and after podocyte injury. During podocyte differentiation, for example, nephrin is transiently phosphorylated on multiple tyrosine residues by the Src family kinase, Fyn [
         <a href="#rid36">
          36
         </a>
         ]. Phosphorylation of nephrin allows its interaction with Nck, which is required for actin reorganization [
         <a href="#rid81">
          81
         </a>
         ]. Decreased nephrin phosphorylation may occur following podocyte injury [
         <a href="#rid36">
          36-38
         </a>
         ]. Nephrin tyrosine phosphorylation is required to stabilize and restore podocyte foot process architecture, and a model has been presented in which changes in phosphotyrosine-based signaling confer plasticity to the podocyte actin cytoskeleton [
         <a href="#rid82">
          82
         </a>
         ].
        </p>
        <p>
         Another possible mechanism of cytoskeletal rearrangement is via the degradation of dynamin, a GTPase protein that is generally considered to have a key role in deforming cellular membranes. Dynamin associates with actin, possibly via the actin-binding protein, cortactin [
         <a href="#rid83">
          83,84
         </a>
         ].
        </p>
        <p>
         Cleavage of dynamin by cathepsin-L may initiate reorganization of the cytoskeleton, resulting in clinical disease. Support for this is provided by findings in animal models and some human glomerular diseases (
         <a class="graphic graphic_figure graphicRef70765" href="/z/d/graphic/70765.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid85">
          85,86
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Levels of cathepsin-L were found to be increased in a murine model of MCD [
         <a href="#rid85">
          85
         </a>
         ]. This increase has also been observed in patients with membranous nephropathy, FSGS, and diabetic nephropathy, although significant increases were not found in those with other proteinuric kidney diseases [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Proteinuria and foot process effacement induced by lipopolysaccharide are abrogated in cathepsin-L-knockout mice [
         <a href="#rid85">
          85
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Whereas the expression of a cathepsin-L-degraded dynamin fragment causes foot process effacement and proteinuria, the expression of cathepsin-L-resistant dynamin mutants decreases proteinuria.
        </p>
        <p>
        </p>
        <p>
         Cytoskeletal rearrangement may also be induced by the urokinase receptor (uPAR) via its activation of the vitronectin receptor, alphavbeta3 integrin [
         <a href="#rid87">
          87
         </a>
         ]. The absence of uPAR, beta3 integrin, or the alphavbeta3 integrin ligand, vitronectin, protects mice from developing lipopolysaccharide-induced proteinuria. This protection is abolished by exogenous expression of either uPAR or a constitutively active beta3 integrin in mice [
         <a href="#rid87">
          87
         </a>
         ]. The uPAR may be required to activate alphavbeta3 integrin in podocytes promoting cell motility and activation of small GTPases.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Direct podocyte injury
         </span>
         <span class="headingEndMark">
          —
         </span>
         Podocytes may be direct targets of injury in acquired proteinuric diseases [
         <a href="#rid88">
          88
         </a>
         ]. Injury may be immunologic or nonimmunologic. An example of an immunologic cause of podocyte injury is the effect of antibodies directed to the phospholipase A2 receptor (PLA2R) in primary membranous nephropathy. This effect is mediated by complement activation leading to the formation of the membrane attack complex and possibly also by interfering with the receptor function [
         <a href="#rid89">
          89
         </a>
         ]. Circulating factors may also lead to severe, recurrent podocyte injury that is reversible [
         <a href="#rid90">
          90
         </a>
         ]. Autoantibodies to the slit diaphragm protein nephrin have been reported in patients with minimal change disease [
         <a href="#rid91">
          91
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3050.html" rel="external">
          "Membranous nephropathy: Pathogenesis and etiology", section on 'Phospholipase A2 receptor'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/117558.html" rel="external">
          "Focal segmental glomerulosclerosis: Pathogenesis", section on 'Putative circulating permeability factors'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3046.html" rel="external">
          "Minimal change disease: Etiology, clinical features, and diagnosis in adults", section on 'Role of B cells'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Nonimmunologic causes of podocyte injury include viral infection (specifically, HIV), drug toxicity (eg,
         <a class="drug drug_general" data-topicid="9736" href="/z/d/drug information/9736.html" rel="external">
          pamidronate
         </a>
         ), local activation of the RAS, and ROS.
        </p>
        <p>
         HIV nephropathy is characterized by collapsing FSGS. (See
         <a class="medical medical_review" href="/z/d/html/14026.html" rel="external">
          "HIV-associated nephropathy (HIVAN)"
         </a>
         .)
        </p>
        <p>
         A number of case reports have documented collapsing glomerulopathy, podocytopathy, and tubulopathy in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [
         <a href="#rid92">
          92-97
         </a>
         ]. Similar to HIV-associated nephropathy (HIVAN), there appears to be an increased risk of collapsing FSGS and podocytopathy in patients carrying high-kidney-risk genetic variants in the
         <em>
          APOL1
         </em>
         gene [
         <a href="#rid73">
          73
         </a>
         ]. Existing models suggest that increased intrinsic expression of
         <em>
          APOL1
         </em>
         within podocytes is necessary for glomerular injury and interferon leads to increased expression of
         <em>
          APOL1
         </em>
         [
         <a href="#rid98">
          98
         </a>
         ], which is present in patients with coronavirus disease 2019 (COVID-19). Intriguingly, collapsing FSGS occurred in the allograft of a transplant recipient infected with SARS-CoV-2; however, the donor
         <em>
          APOL1
         </em>
         genotype was determined to be low risk and the recipient's
         <em>
          APOL1
         </em>
         genotype was high risk (G1/G2), suggesting that extrarenal expression of
         <em>
          APOL1
         </em>
         high-risk variants may be pathogenic [
         <a href="#rid92">
          92
         </a>
         ].
        </p>
        <p>
         Clinical studies and animal models have shown that the podocyte is directly infected by HIV genes and may provide a reservoir for replicating virus [
         <a href="#rid99">
          99,100
         </a>
         ]. Exogenous expression of HIV genes, Nef and Vpr, causes dedifferentiation, proliferation and loss of contact inhibition, and apoptosis of podocytes [
         <a href="#rid99">
          99-106
         </a>
         ]. It is not yet clear whether SARS-CoV-2 virus is directly toxic to the podocyte, although identification of virus in podocytes has been reported in kidney biopsies from patients [
         <a href="#rid107">
          107-109
         </a>
         ]. Furthermore, podocytes have been reported to express all components required for SARS-CoV-2 entry including the ACE2 receptor, the TRPMSS2 protease, and furin [
         <a href="#rid110">
          110,111
         </a>
         ]. Finally, some believe that parvo B19 virus may have similar toxic effects as HIV on podocyte [
         <a href="#rid88">
          88
         </a>
         ].
        </p>
        <p>
         Inhibition of systemic RAS limits the progression of chronic kidney disease in the setting of proteinuria [
         <a href="#rid112">
          112
         </a>
         ]. This is due, in part, to a reduction of transglomerular pressure. However, locally produced angiotensin may also have direct toxic effects on the podocyte. Angiotensin receptor-1 and -2 are expressed by podocytes [
         <a href="#rid113">
          113
         </a>
         ]. Mechanical strain of cultured podocytes increases expression of the angiotensin receptor-1 as well as angiotensin-II and enhances podocyte apoptosis, which is abrogated by angiotensin receptor blockade [
         <a href="#rid68">
          68
         </a>
         ]. Furthermore, a transgenic rat that overexpresses the angiotensin receptor-1, specifically in podocytes, is characterized by proteinuria and structural changes in the podocyte that include effacement and detachment [
         <a href="#rid114">
          114
         </a>
         ]. The prorenin receptor is highly expressed on podocytes and promotes podocyte function and survival by maintaining autophagy and protein turnover machinery. It also contributes to the control of lysosomal pH, which is important for podocyte survival and cytoskeletal integrity [
         <a href="#rid115">
          115
         </a>
         ].
        </p>
        <p>
         ROS are produced in a number of conditions including PAN nephrosis [
         <a href="#rid116">
          116
         </a>
         ], complement activation, and metabolic disorders such as obesity. In patients with obesity that are prone to develop FSGS, albuminuria is negatively correlated with plasma adiponectin, while adiponectin knockout mice exhibit albuminuria and effacement of podocyte foot processes. The protective effect of adiponectin seems to occur through activation of adiponectin receptors expressed on the podocyte membrane and reduction of oxidative stress [
         <a href="#rid117">
          117
         </a>
         ].
        </p>
        <p>
         A number of signaling pathways may lead to podocyte injury and proteinuria:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In human proteinuric kidney diseases such as diabetic nephropathy and FSGS, upregulation of Wnt1 and active beta-catenin is observed in podocytes, while podocyte-specific knockout of beta-catenin protects against development of albuminuria [
         <a href="#rid118">
          118
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Podocytes possess the complete machinery for glutamatergic signaling, and derangements in that signaling may lead to proteinuric kidney diseases [
         <a href="#rid119">
          119
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The Notch pathway seems to be involved in the development of proteinuria because Notch intracellular domain is detected in injured podocytes and genetic inactivation or pharmacologic inhibition of Notch ameliorates proteinuria and podocyte damage [
         <a href="#rid120">
          120,121
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         AKT2, a member of the AKT family of serine/threonine kinases that regulate adaptation to many cellular stress-induced processes, has an essential role in podocyte protection after nephron reduction. This protein triggers a compensatory mechanism that involves mouse double minute-2 homolog (Mdm2), glycogen synthase kinase-3 (Gsk3), and Rac1. AKT2 activation by mammalian (mechanistic) target of rapamycin complex-2 (mTORC2) is also required for podocyte survival in human chronic kidney disease. These data provide an explanation for the adverse kidney effect of
         <a class="drug drug_general" data-topicid="10329" href="/z/d/drug information/10329.html" rel="external">
          sirolimus
         </a>
         and a criterion for the rational use of this drug [
         <a href="#rid122">
          122
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Calcium/calmodulin-dependent protein kinase IV (CaMK4) is a serine-threonine kinase that regulates multiple aspects of the immune response. In rodent models of lupus nephritis and non-immune podocytopathies, expression of CaMK4 is increased [
         <a href="#rid123">
          123
         </a>
         ]. Targeted inhibition of CaMK4 in podocytes is protective, reversing effects of increased CaMK4 on Rac1-mediated podocyte motility and phosphorylation of the scaffold protein 14-3-3, which leads to degradation of synaptopodin [
         <a href="#rid123">
          123
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Programmed cell death protein 1 (PD-1) surface receptor and its two ligands (PD-L1 and PD-L2) are increased in podocytes isolated from aged mice, and
         <em>
          PDCD1
         </em>
         transcript is increased with age in microdissected human glomeruli. Administration of anti-PD-1 antibody increased the life span of podocytes and improved podocyte number and lowered proteinuria in young mice with FSGS [
         <a href="#rid124">
          124
         </a>
         ].
        </p>
        <p>
         Podocyte-specific deletion of Dicer, an enzyme that generates microRNA (small, noncoding RNA that function as important regulators of gene expression) alters cytoskeletal dynamics and induces proteinuria and glomerulosclerosis [
         <a href="#rid123">
          123,125,126
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Podocyte depletion
         </span>
         <span class="headingEndMark">
          —
         </span>
         A decrease in podocyte number resulting from apoptosis or detachment from the GBM may contribute to proteinuria and progressive glomerulosclerosis [
         <a href="#rid127">
          127-130
         </a>
         ]. In many glomerular disorders that are characterized by hypertrophy, the volume of the glomerular tuft increases, despite the decrease in podocyte number [
         <a href="#rid129">
          129
         </a>
         ]. The resulting decrease in podocyte density causes areas of denuded GBM, which are foci for adhesions to parietal epithelial cells and eventual crescent formation [
         <a href="#rid128">
          128
         </a>
         ].
        </p>
        <p>
         Glomerular filtration subjects podocytes to both tensile and shear stress. Attachment of podocytes through interactions among the actin cytoskeleton, the underlying GBM, and integrins protects against tensile stress. Shear stress increases as filtration rate and filtration fraction increase, producing forces on lateral walls of opposing foot processes as well as on podocyte cell bodies. Protection against shear stress and podocyte detachment is thought to be provided by the slit diaphragm [
         <a href="#rid131">
          131
         </a>
         ]. As the hydrostatic and hence shear pressures are highest at the beginning of the glomerular capillary tuft, it has been postulated that podocytes in this region may be the most prone to injury, helping to explain the heterogeneity of podocyte damage that occurs in diseases such as FSGS and why RAS blockade is so effective at protecting against podocyte injury. Some experts have hypothesized that as the filtration and shear stress become close to the danger level for detachment, podocytes respond by effacement, effectively converting the slit diaphragm to a tight junction, which will help prevent massive widening of the slit [
         <a href="#rid58">
          58,59
         </a>
         ].
        </p>
        <p>
         Podocytes and their specific molecular markers have been identified in urine from patients and rodent disease models, providing a possible readout for podocyte detachment and a biomarker for podocyte depletion and glomerular injury [
         <a href="#rid132">
          132
         </a>
         ]. The presence of podocyte-specific messenger RNAs (mRNAs) in the urine may result from shed podocytes and/or exosomes or microvesicles derived from podocytes.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Proteinuria as a toxin
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although massive proteinuria may occur in the absence of obvious structural change in the slit diaphragm and foot processes, a sustained proteinuria event is invariably eventually associated with foot process effacement [
         <a href="#rid79">
          79,133-136
         </a>
         ]. The mechanism underlying this phenomenon is unclear. One possibility is that exposure of podocytes to an increased concentration of albumin and immunoglobulin G (IgG) is sufficient to induce changes in the cytoskeleton [
         <a href="#rid137">
          137
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Glomerular capillary wall
         </strong>
         – The glomerular capillary wall consists of the fenestrated capillary endothelium, glomerular basement membrane (GBM), and glomerular podocytes (or epithelial cells). Defects in any of the three components of the glomerular capillary wall can lead to proteinuria. (See
         <a class="local">
          'Glomerular capillary wall'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Podocytes
         </strong>
         – Glomerular podocytes are terminally differentiated epithelial cells that have large cell bodies and long primary or major processes. The primary processes attach to the underlying GBM via multiple foot processes. (See
         <a class="local">
          'Podocytes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Slit diaphragm
         </strong>
         – The interdigitating foot processes of adjacent podocytes are joined laterally by slit diaphragms that bridge the intervening filtration slits. A number of proteins have been found to comprise the slit diaphragm; these include nephrin, neph1, neph2, FAT1, FAT2, podocin, transient receptor potential cation channel 6 (TRPC6), and tight junction proteins. (See
         <a class="local">
          'Slit diaphragm'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Foot process effacement
         </strong>
         – Foot process effacement of glomerular podocytes is a characteristic histologic finding associated with glomerular diseases affecting the podocyte. Rearrangement of the actin cytoskeleton is necessary for foot process effacement to occur. (See
         <a class="local">
          'Foot process effacement and cytoskeleton rearrangement'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cytoskeletal arrangement
         </strong>
         – Possible molecular mechanisms underlying cytoskeletal rearrangement include phosphorylation/dephosphorylation of nephrin and cleavage of dynamin (a GTPase protein) by cathepsin-L. Activation of the urokinase receptor (uPAR) and initiation of beta3 integrin signaling may also be involved. (See
         <a class="local">
          'Foot process effacement and cytoskeleton rearrangement'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3750370916">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The editorial staff at UpToDate acknowledge Pierre Ronco, MD, who contributed to a previous version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Hausmann R, Kuppe C, Egger H, et al. Electrical forces determine glomerular permeability. J Am Soc Nephrol 2010; 21:2053.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oken DE, Flamenbaum W. Micropuncture studies of proximal tubule albumin concentrations in normal and nephrotic rats. J Clin Invest 1971; 50:1498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tojo A, Endou H. Intrarenal handling of proteins in rats using fractional micropuncture technique. Am J Physiol 1992; 263:F601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russo LM, Sandoval RM, McKee M, et al. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int 2007; 71:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gekle M. Renal albumin handling: a look at the dark side of the filter. Kidney Int 2007; 71:479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Birn H, Christensen EI. Renal albumin absorption in physiology and pathology. Kidney Int 2006; 69:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Comper WD, Haraldsson B, Deen WM. Resolved: normal glomeruli filter nephrotic levels of albumin. J Am Soc Nephrol 2008; 19:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peti-Peterdi J, Kidokoro K, Riquier-Brison A. Novel in vivo techniques to visualize kidney anatomy and function. Kidney Int 2015; 88:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smithies O. Why the kidney glomerulus does not clog: a gel permeation/diffusion hypothesis of renal function. Proc Natl Acad Sci U S A 2003; 100:4108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akilesh S, Huber TB, Wu H, et al. Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci U S A 2008; 105:967.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dobrinskikh E, Okamura K, Kopp JB, et al. Human podocytes perform polarized, caveolae-dependent albumin endocytosis. Am J Physiol Renal Physiol 2014; 306:F941.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chung JJ, Huber TB, Gödel M, et al. Albumin-associated free fatty acids induce macropinocytosis in podocytes. J Clin Invest 2015; 125:2307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gagliardini E, Conti S, Benigni A, et al. Imaging of the porous ultrastructure of the glomerular epithelial filtration slit. J Am Soc Nephrol 2010; 21:2081.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kalluri R. Proteinuria with and without renal glomerular podocyte effacement. J Am Soc Nephrol 2006; 17:2383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh A, Satchell SC, Neal CR, et al. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol 2007; 18:2885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int 2008; 74:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suh JH, Miner JH. The glomerular basement membrane as a barrier to albumin. Nat Rev Nephrol 2013; 9:470.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008; 358:1129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clement LC, Avila-Casado C, Macé C, et al. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 2011; 17:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kerjaschki D. Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 2001; 108:1583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 2006; 354:1387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kestilä M, Lenkkeri U, Männikkö M, et al. Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell 1998; 1:575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Donoviel DB, Freed DD, Vogel H, et al. Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol 2001; 21:4829.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sellin L, Huber TB, Gerke P, et al. NEPH1 defines a novel family of podocin interacting proteins. FASEB J 2003; 17:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ihalmo P, Palmén T, Ahola H, et al. Filtrin is a novel member of nephrin-like proteins. Biochem Biophys Res Commun 2003; 300:364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barletta GM, Kovari IA, Verma RK, et al. Nephrin and Neph1 co-localize at the podocyte foot process intercellular junction and form cis hetero-oligomers. J Biol Chem 2003; 278:19266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ciani L, Patel A, Allen ND, ffrench-Constant C. Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype. Mol Cell Biol 2003; 23:3575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boute N, Gribouval O, Roselli S, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000; 24:349.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reiser J, Polu KR, Möller CC, et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005; 37:739.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winn MP, Conlon PJ, Lynn KL, et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005; 308:1801.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fukasawa H, Bornheimer S, Kudlicka K, Farquhar MG. Slit diaphragms contain tight junction proteins. J Am Soc Nephrol 2009; 20:1491.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Itoh M, Nakadate K, Horibata Y, et al. The structural and functional organization of the podocyte filtration slits is regulated by Tjp1/ZO-1. PLoS One 2014; 9:e106621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwarz K, Simons M, Reiser J, et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001; 108:1621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huber TB, Kottgen M, Schilling B, et al. Interaction with podocin facilitates nephrin signaling. J Biol Chem 2001; 276:41543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huber TB, Schermer B, Müller RU, et al. Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. Proc Natl Acad Sci U S A 2006; 103:17079.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verma R, Kovari I, Soofi A, et al. Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J Clin Invest 2006; 116:1346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uchida K, Suzuki K, Iwamoto M, et al. Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis. Kidney Int 2008; 73:926.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones N, New LA, Fortino MA, et al. Nck proteins maintain the adult glomerular filtration barrier. J Am Soc Nephrol 2009; 20:1533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rinschen MM, Wu X, König T, et al. Phosphoproteomic analysis reveals regulatory mechanisms at the kidney filtration barrier. J Am Soc Nephrol 2014; 25:1509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hartleben B, Schweizer H, Lübben P, et al. Neph-Nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarity. J Biol Chem 2008; 283:23033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huber TB, Hartleben B, Winkelmann K, et al. Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic syndrome. J Am Soc Nephrol 2009; 20:798.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirose T, Satoh D, Kurihara H, et al. An essential role of the universal polarity protein, aPKClambda, on the maintenance of podocyte slit diaphragms. PLoS One 2009; 4:e4194.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Faul C, Asanuma K, Yanagida-Asanuma E, et al. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 2007; 17:428.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Endlich N, Schordan E, Cohen CD, et al. Palladin is a dynamic actin-associated protein in podocytes. Kidney Int 2009; 75:214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ichimura K, Kurihara H, Sakai T. Actin filament organization of foot processes in rat podocytes. J Histochem Cytochem 2003; 51:1589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rastaldi MP, Armelloni S, Berra S, et al. Glomerular podocytes contain neuron-like functional synaptic vesicles. FASEB J 2006; 20:976.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prabakaran T, Nielsen R, Larsen JV, et al. Receptor-mediated endocytosis of α-galactosidase A in human podocytes in Fabry disease. PLoS One 2011; 6:e25065.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bechtel W, Helmstädter M, Balica J, et al. Vps34 deficiency reveals the importance of endocytosis for podocyte homeostasis. J Am Soc Nephrol 2013; 24:727.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prabakaran T, Christensen EI, Nielsen R, Verroust PJ. Cubilin is expressed in rat and human glomerular podocytes. Nephrol Dial Transplant 2012; 27:3156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamamoto-Nonaka K, Koike M, Asanuma K, et al. Cathepsin D in Podocytes Is Important in the Pathogenesis of Proteinuria and CKD. J Am Soc Nephrol 2016; 27:2685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mallipattu SK, Horne SJ, D'Agati V, et al. Krüppel-like factor 6 regulates mitochondrial function in the kidney. J Clin Invest 2015; 125:1347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang W, Wang Y, Long J, et al. Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab 2012; 15:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ayanga BA, Badal SS, Wang Y, et al. Dynamin-Related Protein 1 Deficiency Improves Mitochondrial Fitness and Protects against Progression of Diabetic Nephropathy. J Am Soc Nephrol 2016; 27:2733.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ising C, Koehler S, Brähler S, et al. Inhibition of insulin/IGF-1 receptor signaling protects from mitochondria-mediated kidney failure. EMBO Mol Med 2015; 7:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hartleben B, Gödel M, Meyer-Schwesinger C, et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 2010; 120:1084.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kawakami T, Gomez IG, Ren S, et al. Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS. J Am Soc Nephrol 2015; 26:1040.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zeng C, Fan Y, Wu J, et al. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies. J Pathol 2014; 234:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kriz W, Shirato I, Nagata M, et al. The podocyte's response to stress: the enigma of foot process effacement. Am J Physiol Renal Physiol 2013; 304:F333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kriz W, Lemley KV. Potential relevance of shear stress for slit diaphragm and podocyte function. Kidney Int 2017; 91:1283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Faul C, Donnelly M, Merscher-Gomez S, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008; 14:931.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ransom RF, Lam NG, Hallett MA, et al. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int 2005; 68:2473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fornoni A, Sageshima J, Wei C, et al. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 2011; 3:85ra46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berg AL, Nilsson-Ehle P, Arnadottir M. Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney Int 1999; 56:1534.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bomback AS, Canetta PA, Beck LH Jr, et al. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial. Am J Nephrol 2012; 36:58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ponticelli C, Passerini P, Salvadori M, et al. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy. Am J Kidney Dis 2006; 47:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindskog A, Ebefors K, Johansson ME, et al. Melanocortin 1 receptor agonists reduce proteinuria. J Am Soc Nephrol 2010; 21:1290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elvin J, Buvall L, Lindskog Jonsson A, et al. Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activation. Am J Physiol Renal Physiol 2016; 310:F846.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Durvasula RV, Petermann AT, Hiromura K, et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65:30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michaud JL, Chaisson KM, Parks RJ, Kennedy CR. FSGS-associated alpha-actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes. Kidney Int 2006; 70:1054.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krendel M, Kim SV, Willinger T, et al. Disruption of Myosin 1e promotes podocyte injury. J Am Soc Nephrol 2009; 20:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kao WH, Klag MJ, Meoni LA, et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008; 40:1185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kopp JB, Smith MW, Nelson GW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40:1175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329:841.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olabisi OA, Zhang JY, VerPlank L, et al. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. Proc Natl Acad Sci U S A 2016; 113:830.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beckerman P, Bi-Karchin J, Park AS, et al. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice. Nat Med 2017; 23:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Toole JF, Schilling W, Kunze D, et al. ApoL1 Overexpression Drives Variant-Independent Cytotoxicity. J Am Soc Nephrol 2018; 29:869.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Egbuna O, Zimmerman B, Manos G, et al. Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. N Engl J Med 2023; 388:969.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hussain S, Romio L, Saleem M, et al. Nephrin deficiency activates NF-kappaB and promotes glomerular injury. J Am Soc Nephrol 2009; 20:1733.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jarad G, Cunningham J, Shaw AS, Miner JH. Proteinuria precedes podocyte abnormalities inLamb2-/- mice, implicating the glomerular basement membrane as an albumin barrier. J Clin Invest 2006; 116:2272.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen Z, Migeon T, Verpont MC, et al. HANAC Syndrome Col4a1 Mutation Causes Neonate Glomerular Hyperpermeability and Adult Glomerulocystic Kidney Disease. J Am Soc Nephrol 2016; 27:1042.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones N, Blasutig IM, Eremina V, et al. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 2006; 440:818.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           New LA, Martin CE, Scott RP, et al. Nephrin Tyrosine Phosphorylation Is Required to Stabilize and Restore Podocyte Foot Process Architecture. J Am Soc Nephrol 2016; 27:2422.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schafer DA. Regulating actin dynamics at membranes: a focus on dynamin. Traffic 2004; 5:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Merrifield CJ, Feldman ME, Wan L, Almers W. Imaging actin and dynamin recruitment during invagination of single clathrin-coated pits. Nat Cell Biol 2002; 4:691.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reiser J, Oh J, Shirato I, et al. Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin. J Biol Chem 2004; 279:34827.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sever S, Altintas MM, Nankoe SR, et al. Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest 2007; 117:2095.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wei C, Möller CC, Altintas MM, et al. Modification of kidney barrier function by the urokinase receptor. Nat Med 2008; 14:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006; 69:2131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ronco P, Debiec H. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care. Lancet 2015; 385:1983.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gallon L, Leventhal J, Skaro A, et al. Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N Engl J Med 2012; 366:1648.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watts AJB, Keller KH, Lerner G, et al. Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology. J Am Soc Nephrol 2022; 33:238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shetty AA, Tawhari I, Safar-Boueri L, et al. COVID-19-Associated Glomerular Disease. J Am Soc Nephrol 2021; 32:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Larsen CP, Bourne TD, Wilson JD, et al. Collapsing Glomerulopathy in a Patient With COVID-19. Kidney Int Rep 2020; 5:935.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peleg Y, Kudose S, D'Agati V, et al. Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection. Kidney Int Rep 2020; 5:940.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Magoon S, Bichu P, Malhotra V, et al. COVID-19-Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis. Kidney Med 2020; 2:488.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma Y, Nasr SH, Larsen CP, et al. COVID-19-Associated Collapsing Focal Segmental Glomerulosclerosis: A Report of 2 Cases. Kidney Med 2020; 2:493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu H, Larsen CP, Hernandez-Arroyo CF, et al. AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL1 High-Risk Genotype. J Am Soc Nephrol 2020; 31:1688.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nichols B, Jog P, Lee JH, et al. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1. Kidney Int 2015; 87:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bruggeman LA, Ross MD, Tanji N, et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000; 11:2079.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winston JA, Bruggeman LA, Ross MD, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001; 344:1979.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sunamoto M, Husain M, He JC, et al. Critical role for Nef in HIV-1-induced podocyte dedifferentiation. Kidney Int 2003; 64:1695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           He JC, Husain M, Sunamoto M, et al. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest 2004; 114:643.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Husain M, D'Agati VD, He JC, et al. HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN. AIDS 2005; 19:1975.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhong J, Zuo Y, Ma J, et al. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 2005; 68:1048.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zuo Y, Matsusaka T, Zhong J, et al. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J Am Soc Nephrol 2006; 17:2832.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah SN, He CJ, Klotman P. Update on HIV-associated nephropathy. Curr Opin Nephrol Hypertens 2006; 15:450.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kudose S, Batal I, Santoriello D, et al. Kidney Biopsy Findings in Patients with COVID-19. J Am Soc Nephrol 2020; 31:1959.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Puelles VG, Lütgehetmann M, Lindenmeyer MT, et al. Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med 2020; 383:590.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Westhoff TH, Seibert FS, Bauer F, et al. Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient. Am J Transplant 2020; 20:3216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ye M, Wysocki J, William J, et al. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 2006; 17:3067.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boucher E, Mayer G, Londono I, Bendayan M. Expression and localization of MT1-MMP and furin in the glomerular wall of short- and long-term diabetic rats. Kidney Int 2006; 69:1570.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Remuzzi G, Ruggenenti P, Perico N. Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med 2002; 136:604.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma M, Sharma R, Greene AS, et al. Documentation of angiotensin II receptors in glomerular epithelial cells. Am J Physiol 1998; 274:F623.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoffmann S, Podlich D, Hähnel B, et al. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 2004; 15:1475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Riediger F, Quack I, Qadri F, et al. Prorenin receptor is essential for podocyte autophagy and survival. J Am Soc Nephrol 2011; 22:2193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mayrhofer C, Krieger S, Huttary N, et al. Alterations in fatty acid utilization and an impaired antioxidant defense mechanism are early events in podocyte injury: a proteomic analysis. Am J Pathol 2009; 174:1191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma K, Ramachandrarao S, Qiu G, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 2008; 118:1645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dai C, Stolz DB, Kiss LP, et al. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 2009; 20:1997.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giardino L, Armelloni S, Corbelli A, et al. Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier. J Am Soc Nephrol 2009; 20:1929.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Niranjan T, Bielesz B, Gruenwald A, et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008; 14:290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El Machhour F, Keuylian Z, Kavvadas P, et al. Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease. J Am Soc Nephrol 2015; 26:1561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Canaud G, Bienaimé F, Viau A, et al. AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat Med 2013; 19:1288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maeda K, Otomo K, Yoshida N, et al. CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease. J Clin Invest 2018; 128:3445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pippin JW, Kaverina N, Wang Y, et al. Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and disease. J Clin Invest 2022; 132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harvey SJ, Jarad G, Cunningham J, et al. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J Am Soc Nephrol 2008; 19:2150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shi S, Yu L, Chiu C, et al. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol 2008; 19:2159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim YH, Goyal M, Kurnit D, et al. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 2001; 60:957.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 2005; 67:404.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99:342.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemley KV, Lafayette RA, Safai M, et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int 2002; 61:1475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kriz W, Lemley KV. A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. J Am Soc Nephrol 2015; 26:258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wickman L, Afshinnia F, Wang SQ, et al. Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. J Am Soc Nephrol 2013; 24:2081.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Topham PS, Kawachi H, Haydar SA, et al. Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. J Clin Invest 1999; 104:1559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           PIRANI CL, POLLAK VE, LANNIGAN R, FOLLI G. THE RENAL GLOMERULAR LESIONS OF PRE-ECLAMPSIA: ELECTRON MICROSCOPIC STUDIES. Am J Obstet Gynecol 1963; 87:1047.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Good KS, O'Brien K, Schulman G, et al. Unexplained nephrotic-range proteinuria in a 38-year-old man: a case of "no change disease". Am J Kidney Dis 2004; 43:933.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Branten AJ, van den Born J, Jansen JL, et al. Familial nephropathy differing from minimal change nephropathy and focal glomerulosclerosis. Kidney Int 2001; 59:693.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morigi M, Buelli S, Angioletti S, et al. In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies. Am J Pathol 2005; 166:1309.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3091 Version 20.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20947631" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Electrical forces determine glomerular permeability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5090064" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Micropuncture studies of proximal tubule albumin concentrations in normal and nephrotic rats.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1415732" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Intrarenal handling of proteins in rats using fractional micropuncture technique.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17228368" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17344895" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Renal albumin handling: a look at the dark side of the filter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16514429" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Renal albumin absorption in physiology and pathology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18216311" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Resolved: normal glomeruli filter nephrotic levels of albumin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25738253" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Novel in vivo techniques to visualize kidney anatomy and function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12655073" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Why the kidney glomerulus does not clog: a gel permeation/diffusion hypothesis of renal function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18198272" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Podocytes use FcRn to clear IgG from the glomerular basement membrane.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24573386" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Human podocytes perform polarized, caveolae-dependent albumin endocytosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25915582" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Albumin-associated free fatty acids induce macropinocytosis in podocytes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21030599" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Imaging of the porous ultrastructure of the glomerular epithelial filtration slit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16914535" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Proteinuria with and without renal glomerular podocyte effacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17942961" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Glomerular endothelial glycocalyx constitutes a barrier to protein permeability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18418356" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Proteinuria in diabetic kidney disease: a mechanistic viewpoint.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23774818" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The glomerular basement membrane as a barrier to albumin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18337603" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : VEGF inhibition and renal thrombotic microangiopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21151138" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11733553" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16571882" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Hereditary proteinuria syndromes and mechanisms of proteinuria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9660941" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11416156" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12424224" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : NEPH1 defines a novel family of podocin interacting proteins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12504092" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Filtrin is a novel member of nephrin-like proteins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12646566" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Nephrin and Neph1 co-localize at the podocyte foot process intercellular junction and form cis hetero-oligomers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12724416" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10742096" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15924139" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15879175" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19478094" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Slit diaphragms contain tight junction proteins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25184792" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : The structural and functional organization of the podocyte filtration slits is regulated by Tjp1/ZO-1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11733557" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11562357" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Interaction with podocin facilitates nephrin signaling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17079490" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16543952" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18256598" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19443634" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Nck proteins maintain the adult glomerular filtration barrier.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24511133" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Phosphoproteomic analysis reveals regulatory mechanisms at the kidney filtration barrier.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18562307" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Neph-Nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19279126" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19142224" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : An essential role of the universal polarity protein, aPKClambda, on the maintenance of podocyte slit diaphragms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17804239" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19116644" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Palladin is a dynamic actin-associated protein in podocytes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14623927" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Actin filament organization of foot processes in rat podocytes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16585060" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Glomerular podocytes contain neuron-like functional synaptic vesicles.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21949853" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Receptor-mediated endocytosis ofα-galactosidase A in human podocytes in Fabry disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23492732" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Vps34 deficiency reveals the importance of endocytosis for podocyte homeostasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22337902" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Cubilin is expressed in rat and human glomerular podocytes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26823550" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Cathepsin D in Podocytes Is Important in the Pathogenesis of Proteinuria and CKD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25689250" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Krüppel-like factor 6 regulates mitochondrial function in the kidney.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22326220" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26825530" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Dynamin-Related Protein 1 Deficiency Improves Mitochondrial Fitness and Protects against Progression of Diabetic Nephropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25643582" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Inhibition of insulin/IGF-1 receptor signaling protects from mitochondria-mediated kidney failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20200449" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25406339" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24870816" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23235479" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : The podocyte's response to stress: the enigma of foot process effacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28501303" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Potential relevance of shear stress for slit diaphragm and podocyte function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18724379" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16316324" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21632984" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10504505" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22722778" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16431252" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20507942" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Melanocortin 1 receptor agonists reduce proteinuria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26887829" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14675034" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Activation of a local tissue angiotensin system in podocytes by mechanical strain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16837921" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : FSGS-associated alpha-actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19005011" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Disruption of Myosin 1e promotes podocyte injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18794854" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18794856" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20647424" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26699492" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28218918" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29180397" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : ApoL1 Overexpression Drives Variant-Independent Cytotoxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36920755" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19497968" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Nephrin deficiency activates NF-kappaB and promotes glomerular injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16886065" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Proteinuria precedes podocyte abnormalities inLamb2-/- mice, implicating the glomerular basement membrane as an albumin barrier.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26260163" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : HANAC Syndrome Col4a1 Mutation Causes Neonate Glomerular Hyperpermeability and Adult Glomerulocystic Kidney Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16525419" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26802179" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Nephrin Tyrosine Phosphorylation Is Required to Stabilize and Restore Podocyte Foot Process Architecture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15180823" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Regulating actin dynamics at membranes: a focus on dynamin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12198492" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Imaging actin and dynamin recruitment during invagination of single clathrin-coated pits.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15197181" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17671649" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18084301" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Modification of kidney barrier function by the urokinase receptor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16688120" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : The podocyte's response to injury: role in proteinuria and glomerulosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26090644" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Pathophysiological advances in membranous nephropathy: time for a shift in patient's care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22533598" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Resolution of recurrent focal segmental glomerulosclerosis after retransplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34732507" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33214201" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : COVID-19-Associated Glomerular Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32292867" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Collapsing Glomerulopathy in a Patient With COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32346659" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32775989" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : COVID-19-Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32775990" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : COVID-19-Associated Collapsing Focal Segmental Glomerulosclerosis: A Report of 2 Cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32561682" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL1 High-Risk Genotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25100047" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11053484" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Renal epithelium is a previously unrecognized site of HIV-1 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11430327" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14531802" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Critical role for Nef in HIV-1-induced podocyte dedifferentiation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15343382" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16260903" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16105035" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16988066" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16775461" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Update on HIV-associated nephropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32680910" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Kidney Biopsy Findings in Patients with COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32402155" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Multiorgan and Renal Tropism of SARS-CoV-2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32713123" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17021266" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16541018" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Expression and localization of MT1-MMP and furin in the glomerular wall of short- and long-term diabetic rats.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11955029" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9530280" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Documentation of angiotensin II receptors in glomerular epithelial cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15153558" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22034640" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Prorenin receptor is essential for podocyte autophagy and survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19264907" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Alterations in fatty acid utilization and an impaired antioxidant defense mechanism are early events in podocyte injury: a proteomic analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18431508" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Adiponectin regulates albuminuria and podocyte function in mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19628668" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19578006" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18311147" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : The Notch pathway in podocytes plays a role in the development of glomerular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25421557" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24056770" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : AKT2 is essential to maintain podocyte viability and function during chronic kidney disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29985166" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35968783" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18776121" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18776119" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11532090" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15673288" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Pathways to nephron loss starting from glomerular diseases-insights from animal models.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9006003" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Podocyte loss and progressive glomerular injury in type II diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11918755" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Podocytopenia and disease severity in IgA nephropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25060060" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : A potential role for mechanical forces in the detachment of podocytes and the progression of CKD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24052633" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10587519" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14089309" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : THE RENAL GLOMERULAR LESIONS OF PRE-ECLAMPSIA: ELECTRON MICROSCOPIC STUDIES.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15112187" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Unexplained nephrotic-range proteinuria in a 38-year-old man: a case of "no change disease".
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11168951" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Familial nephropathy differing from minimal change nephropathy and focal glomerulosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15855633" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
